Study Design of a Phase 3, Randomized, Open-Label, Multicenter Study to Evaluate Ruxolitinib Over BAT in Patients with Corticosteroid-Refractory Chronic Graft vs Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation (REACH-3) Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Zeiser, Robert
  • Ram, Ron
  • Foley, Ronan
  • Yeshurun, Moshe
  • Locatelli, Franco
  • Artz, Andrew
  • Gadbaw, Brian
  • Atienza, Edric
  • Hollaender, Norbert
  • Delaite, Patricia
  • Teshima, Takanori

publication date

  • March 1, 2018